Mind Med is the first psychedelic company to IPO. Backed by big names from big brands, Shark Tank and Tom's Shoes and Canopy Growth. MMED has in its portfolio (1) psychedelic-derived drug for the treatment of opiate addiction made from indigenous African plant iboga used in religious rituals for thousands of years (2) LSD microdosing trials.
+
10x potential....
Keep it simple stupid.
I will buy on breakout to the upside with volume. Or, more conservatively, wait for a retest after breakout.
Entry around $16.5. Resistance levels marked on the chart at $20, $23, $27, etc.
Why would I make this trade?
> CORN consolidating...CORNSOLIDATING!
> RSI Increasing
> Equity prices are falling across the board. See the DOW...
